Can the franchisor provide a detailed breakdown of the 17 unit terminations in 2024, including specific reasons (franchisor-initiated vs. franchisee-initiated non-compliance) and which clauses were violated?
#1
What triggered the sharp increase in closures and terminations starting in 2023-2024 after a period of rapid expansion with minimal exits in 2021-2022?
#2
All 9 litigation cases from the past 3 years remain pending. What is the status, nature, and estimated resolution timeline for each case, particularly the 7 cases where the franchisor is a defendant?
#3
Of the 2 cases where the franchisor was plaintiff, what were the outcomes and what specific franchise violations were involved?
#4
The franchise fee of $60,000 exceeds the typical range for this category. What specific services, training, or support justify this premium pricing?
#5
Why does the technology fee of $150/month fall below the typical range of $165-$427.50 for this category, and are there additional technology-related costs not captured in this fee?
#6
Can you provide the underlying financial performance data (Item 19) broken down by unit age, location type (clinic-based vs. virtual), and franchisee tenure to assess which units are underperforming?
#7
The non-compete clause restricts franchisees from providing outpatient counseling or therapy services within 10 miles for 2 years post-termination. How is this enforced, and have any disputes arisen regarding this restriction?
#8
What are the 8 non-curable defaults in the termination clause, and under what circumstances has the franchisor exercised termination rights versus allowing franchisees to cure defaults?
#9
The renewal conditions require 8 specified criteria. How many franchisees have successfully renewed, how many have been denied renewal, and what were the reasons for any denials?
#10
Required purchases from approved vendors include onboarding packages, EHR systems, and credentialing/billing services. Can franchisees use alternative vendors, and what percentage of ongoing franchisor revenue comes from these required purchases?
#11
Are the 17 units terminated in 2024 geographically clustered, and if so, does this indicate market saturation, encroachment by new franchisees, or franchisor-initiated consolidation?
#12
How many of the 255 current units are company-owned versus franchisee-owned, and how have the financial metrics (median/average gross sales) been affected by unit closures in 2024?
#13
The binding arbitration requirement specifies Minnesota as the forum under state law. What is the typical cost and duration of arbitration disputes, and has the franchisor pursued arbitration in any of the 9 pending cases?
#14
Personal guaranties are required from each owner and spouse. In cases of unit termination or failure, have personal guaranties been enforced against franchisees' personal assets?
#15
What support and training (scored 83/100) is provided to help franchisees reach the median gross sales of $583,136, and what percentage of franchisees fall below the median?
#16
The system grew from 36 units (2021) to 263 currently at a 92% CAGR. What was the unit recruitment strategy during this expansion, and has rapid growth contributed to higher termination rates?
#17
Are there any ongoing regulatory investigations or complaints from state licensing boards related to the therapy/counseling services provided by franchisees?
#18
What is the average franchisee net profit or EBITDA after all fees (royalty, technology, renewal, etc.), and how does this compare to the claimed gross sales figures?
#19